. Correction to "Long-term safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with obesity and without type 2 diabetes: A global retrospective cohort study". Diabetes Obes Metab 2025 Jan 13. doi: 10.1111/dom.16204.
PMID: 39803719